1. Home
  2. OLMA vs SFST Comparison

OLMA vs SFST Comparison

Compare OLMA & SFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • SFST
  • Stock Information
  • Founded
  • OLMA 2006
  • SFST 1999
  • Country
  • OLMA United States
  • SFST United States
  • Employees
  • OLMA N/A
  • SFST N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • SFST Major Banks
  • Sector
  • OLMA Health Care
  • SFST Finance
  • Exchange
  • OLMA Nasdaq
  • SFST Nasdaq
  • Market Cap
  • OLMA 299.7M
  • SFST 335.4M
  • IPO Year
  • OLMA 2020
  • SFST 1999
  • Fundamental
  • Price
  • OLMA $5.76
  • SFST $44.94
  • Analyst Decision
  • OLMA Strong Buy
  • SFST Buy
  • Analyst Count
  • OLMA 5
  • SFST 1
  • Target Price
  • OLMA $24.00
  • SFST $51.00
  • AVG Volume (30 Days)
  • OLMA 532.6K
  • SFST 26.3K
  • Earning Date
  • OLMA 08-11-2025
  • SFST 10-21-2025
  • Dividend Yield
  • OLMA N/A
  • SFST N/A
  • EPS Growth
  • OLMA N/A
  • SFST 58.48
  • EPS
  • OLMA N/A
  • SFST 2.69
  • Revenue
  • OLMA N/A
  • SFST $102,878,000.00
  • Revenue This Year
  • OLMA N/A
  • SFST $6.08
  • Revenue Next Year
  • OLMA N/A
  • SFST $13.23
  • P/E Ratio
  • OLMA N/A
  • SFST $16.69
  • Revenue Growth
  • OLMA N/A
  • SFST 15.60
  • 52 Week Low
  • OLMA $2.86
  • SFST $29.14
  • 52 Week High
  • OLMA $13.93
  • SFST $45.99
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 63.92
  • SFST 67.24
  • Support Level
  • OLMA $5.34
  • SFST $41.10
  • Resistance Level
  • OLMA $5.78
  • SFST $42.40
  • Average True Range (ATR)
  • OLMA 0.34
  • SFST 1.12
  • MACD
  • OLMA 0.05
  • SFST 0.11
  • Stochastic Oscillator
  • OLMA 85.90
  • SFST 98.89

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About SFST Southern First Bancshares Inc.

Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.

Share on Social Networks: